Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

The Flagship Initiative to Accelerate Cell Therapies, An Anticipated Pathway to Cures for Type 1 Diabetes, Is Made Possible by Initial Transformational Gifts Totaling $75 Million Project ACT will be ...

Insulet’s Omnipod 5 automated insulin delivery (AID) system has multiple avenues to expand as it has revolutionized the way patients treat their diabetes, including the new indication for Type 2 ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

England's NHS is testing an artificial pancreas for children with Type 1 diabetes, a device already available in India.

It is expected that India will have 10,000 deep-tech start-ups by 2030. A few of the start-ups were showcased during a joint ...

SAN DIEGO, CA / ACCESSWIRE / November 11, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump ...

The 39 year-old star of TV, film and stage has battled with the potentially fatal condition since his early 20s, but has ...

Jean Langford, a member of the International Diabetes Federation Europe’s YOURAH network, says one- size- fits all care for diabetes ...

"According to the latest study from BCC Research "Infusion Pumps and Devices: Technologies and Global Markets," the global market is expected to grow from $10.1 billion in 2024 to $14.7 billion by the ...

Most notably, more than half our pump shipments were new to customers ... that there is no one-size-fits-all solution in insulin therapy management, and that the needs and preferences in diabetes ...